As a result of this shocking news, the price of NPS Pharmaceuticals stock plunged more than 39%, falling from $8.21 …
Shares of major biotech companies stumbled Friday on concerns the sector may be overheated. The iShares NASDAQ …
Currently, people afflicted with the disease may take almost 50 calcium supplements in a day, says Nader, chief executive of biotech NPS Pharmaceuticals (NPSP ... the good news from the study data, NPS's stock's rally was short-lived …
LINN pays an annual dividend of $2.64 for a 6.85% yield. Top Stock to Buy #4 NPS Pharmaceuticals (NPSP) Small-cap biotech company NPS Pharmaceuticals Inc. (NASDAQ: NPSP) is developing therapeutics for gastrointestinal and …
so the stock should be in strong hands. Once it gets moving higher, you shouldn’t see a lot of sellers. This is the strategy that helped my subscribers earn a gain of 775% on NPS Pharmaceuticals, Inc.(NASDAQ:NPSP) and more than …
Yang downgraded the rating on NPS Pharmaceuticals (NASDAQ ... Gattex U.S. launch in 2013 and anticipation of bigger Natpara opportunity resulted in strong stock performance. Now trading at ~17.2x EV/'14 revenue (vs. ~16.1x for BMRN …
NPS Pharmaceuticals Inc., which agreed to buy a rival, Enzon Pharmaceuticals Inc., for $770 million in stock, said the companies had called off the takeover after failing to agree on a final price. NPS wanted to renegotiate the terms of the …
NPS Pharmaceuticals (NPSP): NPSP is a new Outperform at Oppenheimer, whose price objective is $18 on a stock it says can continue to reap benefits from its twin principal products Gattex and Natpara. Perrigo (PRGO): The consumer …
(Reuters) - Dublin-based Shire Plc (SHP.L), whose proposed sale to AbbVie Inc (ABBV.N) fell apart in October, is considering an offer for U.S-based drug developer NPS Pharmaceuticals ... up 1.3 percent on the London Stock
New York, NY - (ACCESSWIRE) - 11/06/2013 - Growing Stock Report initiates its NASDAQ Active Stock Watch List adding Myriad Genetics Inc. (NASDAQ:MYGN - News), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP - News), Durata …